The Valley Desk

NCT05127954 · Interventional trial

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)

Overall registry status Enrolling by invitation

Phase 3

Conditions Migraine

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov